Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Razo

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Pharmaceutical Education|December 25, 2019
Using Testing as a Learning ToolBrenda W Yang, Juan Razo, Adam M Persky
Antibodies (Basel, Switzerland)|September 24, 2019
Factors Affecting the Pharmacology of Antibody-Drug ConjugatesAndrew T Lucas, Lauren S L Price, Allison N Schorzman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancerSarah E Taylor, Jennifer S Petschauer, Heidi Donovan, et al.
Pharmacogenomics|November 5, 2010
Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipientsPing Wang, Yong Mao, Juan Razo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Pharmaceutical Education|December 25, 2019
Using Testing as a Learning ToolBrenda W Yang, Juan Razo, Adam M Persky
Antibodies (Basel, Switzerland)|September 24, 2019
Factors Affecting the Pharmacology of Antibody-Drug ConjugatesAndrew T Lucas, Lauren S L Price, Allison N Schorzman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancerSarah E Taylor, Jennifer S Petschauer, Heidi Donovan, et al.
Pharmacogenomics|November 5, 2010
Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipientsPing Wang, Yong Mao, Juan Razo, et al.
Pageof 1